NS

Nachhattar Singh Toor

Director Director DIN 01815717
DIN 01815717 First appointment Oct 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2007
Shareholding value •••• Premium profile

About Nachhattar Singh Toor

Data last updated:

Nachhattar Singh Toor was a Director at Richmond Biosciences Private Limited (2007–2015) and Director at Synectics Technology Private Limited (2010–2011). The companies operate in Pharma and Software.

DIN 01815717
Primary Designation Director
Industry Pharma
First Appointment 08 Oct 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Richmond Biosciences Private Limited U24110TG1989PTC009623
Director08 Oct 20071989₹8.3 Lakh (FY 2022)Active
Synectics Technology Private Limited U72200KA2010PTC052138
Director12 Jan 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Richmond Biosciences Private Limited
Synectics Technology Private Limited
Premium access

Shareholding and investment profile for Nachhattar Singh Toor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nachhattar Singh Toor

Nachhattar Singh Toor was first appointed on 08 Oct 2007 as Director at Richmond Biosciences Private Limited. The most recent appointment on record is 12 Jan 2010 at Synectics Technology Private Limited.

Nachhattar Singh Toor held 2 earlier board appointments: Richmond Biosciences Private Limited (Director, 08 Oct 2007 to 26 Jun 2015); Synectics Technology Private Limited (Director, 12 Jan 2010 to 30 Nov 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available